banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

MIRA Pharmaceuticals Ignites the Market: Breakthrough Pain Drug Data Fuels Massive Stock Surge

Folks, buckle up because the market’s got a live wire today, and it’s all about MIRA Pharmaceuticals (NASDAQ: MIRA). As of this writing, shares are blasting off more than 60%, turning heads and lighting up trading screens from coast to coast. If you’re dipping your toes into stocks, this is the kind of fireworks that … Read more

Quoin Pharmaceuticals Skyrockets Over 200% on Game-Changing $104.5 Million Cash Infusion – Is This the Spark Biotech Investors Have Been Waiting For?

Listen, folks, if you’re glued to the markets like I am, you know those days when a stock just explodes out of nowhere? Today, October 10, 2025, that’s exactly what’s happening with Quoin Pharmaceuticals (NASDAQ: QNRX). As of this writing, early in the trading session, shares are up a jaw-dropping 217% – yeah, you read … Read more

Trump’s 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for US consumers’

President Trump’s overnight decision to impose a 100% tariff on imported pharmaceuticals starting October 1 is already whacking the stock prices of foreign drug companies as analysts struggle to digest how damaging the hit to the drug business will be. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or … Read more

Telomir Pharmaceuticals Soars on Breakthrough Cancer and Aging Data

Folks, hold onto your hats because Telomir Pharmaceuticals (NASDAQ: TELO) is making waves in the stock market today! As of this writing, the stock is surging a jaw-dropping 35% in after-hours trading, climbing to $2.00 after closing the regular session at $1.48. What’s got investors so excited? It’s all about Telomir-1, their lead drug candidate … Read more

U.S. and EU spell out tariffs for autos, pharmaceuticals, and more

U.S. President Donald Trump shakes hands with President of the European Commission Ursula von der Leyen as he announces a trade deal with the EU at Trump Turnberry golf club on July 27, 2025 in Turnberry, Scotland. U.S. Andrew Harnik | Getty Images News | Getty Images The U.S. and European Union on Thursday revealed … Read more

Trump threatens to impose 200% tariffs on pharmaceuticals

Donald Trump has said that the US will impose a roughly 50 per cent tariff on copper imports, sending prices for the industrial metal soaring and escalating his global trade war. The president said at a cabinet meeting on Tuesday that “today we’re doing copper”, adding that he believed the levy on the metal would … Read more

InMed Pharmaceuticals Soars on Alzheimer’s Breakthrough: What’s Driving the Surge?

Buckle up, traders! As of this writing, InMed Pharmaceuticals Inc. (NASDAQ: INM) is lighting up the market with a jaw-dropping gain of over 100%, trading at $4.91 per share. This tiny biotech, headquartered in Vancouver, Canada, is making waves with a game-changing announcement that’s got investors buzzing. So, what’s the deal? Let’s dive into the … Read more

Processa Pharmaceuticals Skyrockets on Game-Changing Gastroparesis Deal

Alright, folks, let’s talk about a stock that’s lighting up the market today—Processa Pharmaceuticals (Nasdaq: PCSA). As of this writing, PCSA is up a jaw-dropping 150% in pre-market trading, and it’s all thanks to a blockbuster announcement that’s got investors buzzing. The company just inked a binding term sheet with Intact Therapeutics, giving them an … Read more

Acurx Pharmaceuticals Soars as Breakthrough Antibiotic Data Hits the Headlines

Buckle up, traders, because Acurx Pharmaceuticals (NASDAQ: ACXP) is stealing the spotlight today, rocketing as one of the market’s biggest gainers as of this writing! This tiny biotech, focused on tackling some of the nastiest bacterial infections out there, just dropped a bombshell that’s got investors buzzing. The company announced the publication of its Phase … Read more

CNS Pharmaceuticals Soars Over 100% on $5 Million Offering: What’s Driving the Surge?

Buckle up, folks, because CNS Pharmaceuticals (NASDAQ: CNSP) is stealing the spotlight today, rocketing over 118% as of this writing! This little biotech dynamo is making waves in the market, and it’s all thanks to a fresh $5 million public offering that’s got investors buzzing. Let’s dive into what’s fueling this explosive move, explore the … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4